Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Brenner

Showing results (271-280 of 298) with videos related to

Pageof 30
Sort By:
Hepatology (Baltimore, Md.)|September 25, 2004
Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in ratsChristopher J Parsons, Blair U Bradford, Clark Q Pan, et al.
Cell Metabolism|November 26, 2019
Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic SteatohepatitisXiaoli Sun, Jason S Seidman, Peng Zhao, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2017
Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver DiseaseCyrielle Caussy, Jun Chen, Mosab H Alquiraish, et al.
Hepatology (Baltimore, Md.)|December 9, 2014
Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)Rohit Loomba, Claude B Sirlin, Brandon Ang, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
LARP6 regulates the mRNA translation of fibrogenic genes in liver fibrosisHyun Young Kim, Orel Mizrahi, Wonseok Lee, et al.
Hepatology (Baltimore, Md.)|November 22, 2017
Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in micePhillipp Hartmann, Katrin Hochrath, Angela Horvath, et al.
The Journal of Clinical Investigation|June 20, 2017
Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosisCyrielle Caussy, Meera Soni, Jeffrey Cui, et al.
Nature Communications|December 10, 2021
CRIg on liver macrophages clears pathobionts and protects against alcoholic liver diseaseYi Duan, Huikuan Chu, Katharina Brandl, et al.
The Journal of Clinical Investigation|July 2, 2014
TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesisSayaka Inokuchi-Shimizu, Eek Joong Park, Yoon Seok Roh, et al.
Cell Metabolism|September 5, 2019
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver DiseaseRohit Loomba, Victor Seguritan, Weizhong Li, et al.
Pageof 30

Showing results (271-280 of 298) with videos related to

Sort By:
Pageof 30
Hepatology (Baltimore, Md.)|September 25, 2004
Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in ratsChristopher J Parsons, Blair U Bradford, Clark Q Pan, et al.
Cell Metabolism|November 26, 2019
Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic SteatohepatitisXiaoli Sun, Jason S Seidman, Peng Zhao, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2017
Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver DiseaseCyrielle Caussy, Jun Chen, Mosab H Alquiraish, et al.
Hepatology (Baltimore, Md.)|December 9, 2014
Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)Rohit Loomba, Claude B Sirlin, Brandon Ang, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
LARP6 regulates the mRNA translation of fibrogenic genes in liver fibrosisHyun Young Kim, Orel Mizrahi, Wonseok Lee, et al.
Hepatology (Baltimore, Md.)|November 22, 2017
Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in micePhillipp Hartmann, Katrin Hochrath, Angela Horvath, et al.
The Journal of Clinical Investigation|June 20, 2017
Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosisCyrielle Caussy, Meera Soni, Jeffrey Cui, et al.
Nature Communications|December 10, 2021
CRIg on liver macrophages clears pathobionts and protects against alcoholic liver diseaseYi Duan, Huikuan Chu, Katharina Brandl, et al.
The Journal of Clinical Investigation|July 2, 2014
TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesisSayaka Inokuchi-Shimizu, Eek Joong Park, Yoon Seok Roh, et al.
Cell Metabolism|September 5, 2019
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver DiseaseRohit Loomba, Victor Seguritan, Weizhong Li, et al.
Pageof 30